Limitations, agreements, and source contact

Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma · Source last updated 2021-05-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

restriction Type

LTE60

restrictive Agreement

true

point Of Contact

email

jmh2004@med.cornell.edu

organization

Weill Cornell Medical College

phone

6469629440

title

Jennifer Hess

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice